Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Discover the importance of the DNA test for Primary Ciliary Dyskinesia (PCD) in Australian Shepherds, a genetic disorder affecting respiratory health. Early detection through PCD DNA testing helps breeders and owners prevent the spread of this inherited condition, ensuring healthier puppies. This test identifies carriers and affected dogs, promoting responsible breeding practices. Regular screening supports the well-being of Australian Shepherds by reducing respiratory complications linked to PCD. Trust reliable laboratories offering accurate and fast DNA test results for PCD. Protect your Australian Shepherd’s future with comprehensive genetic testing today. Stay informed and keep your dog healthy with PCD DNA testing.
Primary Ciliary Dyskinesia (PCD) is a genetic disorder affecting the cilia function in Australian Shepherds, leading to respiratory issues and reduced mobility of airway cells. A DNA test for PCD helps identify carriers and affected dogs, enabling responsible breeding decisions. Early detection through testing can improve management and care for affected dogs. This test is crucial for maintaining the health and longevity of the breed. Breeders and owners are encouraged to use DNA testing to prevent the spread of PCD in Australian Shepherd populations.
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Primary Ciliary Dyskinesia (PCD) is a genetic disorder that affects the motility of cilia, which are tiny hair-like structures that line the respiratory tract and other parts of the body. In healthy dogs, these cilia help to clear mucus and debris from the airways, ensuring proper respiratory function. However, in dogs affected by PCD, the cilia do not function correctly, leading to a range of respiratory issues.
Dogs with PCD often exhibit a variety of respiratory symptoms, including chronic cough, nasal discharge, and frequent respiratory infections. The impaired clearance of mucus can result in the accumulation of pathogens in the airways, which increases the risk of pneumonia and other serious respiratory conditions. Other potential symptoms may include reduced exercise tolerance and lethargy, as affected dogs struggle to breathe easily.
The condition is caused by mutations in genes that are crucial for the proper structure and function of cilia. In Australian Shepherds, specific genetic markers have been identified that are associated with PCD. Understanding the genetic basis of this condition is vital for breeders and dog owners, as it allows for informed breeding decisions to reduce the prevalence of PCD in the breed.
DNA testing plays a critical role in identifying Australian Shepherds that carry the genetic mutations associated with PCD. Testing can help breeders make educated choices, thereby minimizing the risk of producing affected puppies. Additionally, it enables dog owners to understand their pet's health status, which can guide management and treatment options if the dog is diagnosed with PCD.
While there is currently no cure for Primary Ciliary Dyskinesia, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups, along with appropriate medical treatment for respiratory infections, are essential. In some cases, supportive therapies such as nebulization or physiotherapy may be recommended to help clear mucus from the airways and improve respiratory function.
Primary Ciliary Dyskinesia is a significant health concern in Australian Shepherds that requires careful consideration by breeders and dog owners. Through DNA testing and a better understanding of the condition, it is possible to reduce its impact on the breed and ensure healthier future generations. Early diagnosis and appropriate management can greatly enhance the well-being of affected dogs, allowing them to lead fulfilling lives.
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
This DNA test detects the mutation associated with Primary Ciliary Dyskinesia In Australian Shepherd (PCD-AS) in order to identify clear, carrier, or at-risk animals.
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
This test analyses the mutation STK36 c.2868-1G>A.
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Christen Matthias, LudwigPeisker Odette, Jagannathan Vidhya, Hetzel Udo, Schönball Ulrike, Leeb Tosso. STK36 splice site variant in an Australian Shepherd dog with primary ciliary dyskinesia. Anim Genet. 2023 Jun;54(3):412-415. doi: 10.1111/age.13306. Epub 2023 Feb 14.
Bo privasidat, bo eskoho
Nos ta usa kuki esensial pa manehá e wèpsait. Kuki opshonal (manera dunadónan di kontenido inkorporá) ta desabilitá pa default i ta wòrdu aktivá solamente si bo ta di akuerdo. Bo por kambia bo eskoho na kualke momento usando e boton “Cookies”.
Ta nesesario pa karakterístikanan prinsipal i seguridat. Semper aktivá.
Ta mehorá funshonnan manera sparmentu di preferensia òf inkorporashon no-propaganda.
Yuda nos komprondé e uso di e wèpsait. Deshabilitá pa default.
Propaganda/tracking atraves di wèpsaitnan (algun video/mapa ta inkorporá). Deshabilitá pa default.